about
Flavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related DiseasesBiologics in dermatologic therapy - an update.Follicle-stimulating hormone, interleukin-1, and bone density in adult women.Effects of hyaluronic acid conjugation on anti-TNF-α inhibition of inflammation in burnsAutologous protein solution prepared from the blood of osteoarthritic patients contains an enhanced profile of anti-inflammatory cytokines and anabolic growth factors.Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year periodExpression of granulocyte colony stimulating factor receptor in human colorectal cancer.Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis.Tumor cell p38 MAPK: A trigger of cancer bone osteolysisPretreatment Prediction of Individual Rheumatoid Arthritis Patients' Response to Anti-Cytokine Therapy Using Serum Cytokine/Chemokine/Soluble Receptor Biomarkers.Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?White blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution.Mechanisms modulating inflammatory osteolysis: a review with insights into therapeutic targets.Role of adalimumab in the management of children and adolescents with juvenile idiopathic arthritis and other rheumatic conditions.The effect of anakinra on retinal function in isolated perfused vertebrate retina.IL-1 mediates TNF-induced osteoclastogenesis.Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors.Cytokine Signatures in Mucocutaneous and Ocular Behçet's Disease.
P2860
Q26746303-ED7FB8F8-A2AE-4F1F-BE25-4FB707CCA807Q33607620-4BC2C760-EAFF-4541-8272-144AA9052B0EQ33728125-CEE1A638-F3BD-4A8F-9A2B-8798EBE4DC49Q33994261-319A8CC0-0DF9-4C7F-B8FE-4996AC0D5E5BQ34052680-82603EDC-5893-4B9F-AF6D-BA344BF9DE41Q34896269-13202CE8-76F8-47CB-8A07-0E048C3ECACDQ35521968-480071B3-D6A5-4129-8244-58C6BD0DE08BQ35553607-7A841F78-1251-4747-BA29-7A480DDA8864Q35662843-7A356CB7-73A1-4A54-8104-A2718BEEB812Q35691806-46F7C684-73BA-4FDC-86C8-442155561920Q35954640-AFBE6A04-045A-4E94-9225-7C9D094D79D9Q36564183-955329F0-C1D8-445C-9BD9-53CEC4025068Q37106639-8F733D7A-C26C-4F69-9AD3-A6F6C7DE391BQ37561994-2ED73E60-5DE7-4CFD-920F-E0E24CBDFEDFQ37716334-9001ADD9-D79F-46FC-AECB-6356B7C7B778Q40909592-FF1F3074-2A77-4683-A747-A42E2BDAC011Q42084566-BFADC1DF-D88C-4AD4-89FA-0DFBA072CCEEQ42119341-5D3D8F8B-8B96-4CA8-AF96-CB19D4E6C07F
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The mode of action of cytokine inhibitors.
@ast
The mode of action of cytokine inhibitors.
@en
The mode of action of cytokine inhibitors.
@nl
type
label
The mode of action of cytokine inhibitors.
@ast
The mode of action of cytokine inhibitors.
@en
The mode of action of cytokine inhibitors.
@nl
prefLabel
The mode of action of cytokine inhibitors.
@ast
The mode of action of cytokine inhibitors.
@en
The mode of action of cytokine inhibitors.
@nl
P1476
The mode of action of cytokine inhibitors.
@en
P2093
William P Arend
P577
2002-09-01T00:00:00Z